Gapapagos and Servier reported topline results from the phase 2 ROCELLA trial, which evaluated GLPG1972/S201086 versus placebo in treating patients with knee osteoarthritis. The trial…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.